Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

Overview of attention for article published in Clinical Pharmacology & Therapeutics, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 3 news outlets
blogs: 2 blogs

twitter: 22 X users

Citations

dimensions_citation: 242 Dimensions

Readers on

mendeley: 283 Mendeley

Summary News Blogs X Dimensions citations

So far, Dimensions has found 242 publications that cite this research output.

242

The most recent citing publications are shown below. View all 242 publications that cite this research output on Dimensions.

Nonlinear Mixed‐Effects Model of Z‐Endoxifen Concentrations in Tamoxifen‐Treated Patients from the CEPAM Cohort

Article in Clinical Pharmacology & Therapeutics (March 2024)

Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data

Article in Clinical and Translational Science (March 2024)

Prevalence of CYP2D6 structural variation in large retrospective study.

Article in Pharmacogenetics and Genomics (February 2024)